当前位置:首页 - 行情中心 - 科兴制药(688136) - 财务分析

科兴制药

(688136)

  

流通市值:74.57亿  总市值:74.57亿
流通股本:2.01亿   总股本:2.01亿

科兴制药(688136)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.09亿元,每股收益0.56元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益171612.59万元,未分配利润24731.30万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产341132.06万元,负债169519.47万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,147,639,140.97700,464,766.25353,559,464.741,406,925,448.3
营业总成本1,070,420,698.89653,551,426.35323,281,678.191,344,390,356.12
其他经营收益
营业利润117,673,761.9186,211,621.5534,117,948.0163,200,515.55
利润总额115,338,711.4684,128,950.231,785,499.9156,902,608.15
净利润109,102,136.3478,962,472.0624,851,106.7627,048,555.4
每股收益
其他综合收益-80,087.15-25,544.5-3,532.561,119,696.97
综合收益总额109,022,049.1978,936,927.5624,847,574.228,168,252.37
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,550,078,576.411,432,193,326.281,323,937,686.61,287,809,760.09
非流动资产:
非流动资产合计1,861,242,018.721,886,100,348.921,869,781,558.191,874,424,768.07
资产总计3,411,320,595.133,318,293,675.23,193,719,244.793,162,234,528.16
流动负债:
流动负债合计1,032,648,614.83913,266,791.04882,260,873.66886,397,364.11
非流动负债:
非流动负债合计662,546,077.37719,913,485.41643,553,980.61636,590,505.55
负债合计1,695,194,692.21,633,180,276.451,525,814,854.271,522,987,869.66
所有者权益(或股东权益):
归属于母公司股东权益合计1,713,948,639.841,682,157,277.011,664,292,398.751,634,908,540.58
股东权益合计1,716,125,902.931,685,113,398.751,667,904,390.521,639,246,658.5
负债和股东权益合计3,411,320,595.133,318,293,675.23,193,719,244.793,162,234,528.16
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计929,454,734.91606,518,800.32310,620,690.741,199,675,882.57
经营活动现金流出小计936,712,263.1576,720,717.59285,175,543.11,093,006,146.16
经营活动产生的现金流量净额-7,257,528.1929,798,082.7325,445,147.64106,669,736.41
投资活动产生的现金流量:
投资活动现金流入小计1,362,838,531.45825,010,393.29348,927,679.481,959,318,497.97
投资活动现金流出小计1,518,701,955.761,026,375,715.58459,264,017.932,063,443,839.64
投资活动产生的现金流量净额-155,863,424.31-201,365,322.29-110,336,338.45-104,125,341.67
筹资活动产生的现金流量:
筹资活动现金流入小计729,011,188.76440,049,226.94176,879,579.9634,619,783.9
筹资活动现金流出小计628,626,263.6376,233,605.33156,215,255.49645,533,991.09
筹资活动产生的现金流量净额100,384,925.1663,815,621.6120,664,324.41-10,914,207.19
汇率变动对现金及现金等价物的影响786,051.791,033,973.31449,313.931,391,169.29
现金及现金等价物净增加额-61,949,975.55-106,717,644.64-63,777,552.47-6,978,643.16
期末现金及现金等价物余额491,001,967.04446,234,297.95489,420,850.82552,951,942.59
补充资料:
现金及现金等价物的净增加额--106,717,644.64--6,978,643.16
最新报告期:2025-10-29
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
财通证券华挺0.530.790.962025-10-29
天风证券杨松,曹文清0.701.091.492025-09-27
华安证券谭国超0.701.021.672025-09-12
华源证券刘闯0.601.031.722025-09-08
申万宏源仰佳佳0.541.021.322025-08-31
TOP↑